McDermott and Bull executive Search
 

Other News

New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia

Rhythm by 0 comments

Early Feasibility Outcomes in a Real-World Patient Cohort of Both Ischemic and Challenging Non-Ischemic Patients Published in Circulation: Arrhythmia and Electrophysiology LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication […]

Continue Reading →

RapidAI Highlights Research Depth and Industry Leadership at ISC 2026 With 28 Clinical Abstracts

Neuro by 0 comments

New clinical data show AI-driven gains in aneurysm growth detection, stroke interpretation accuracy, and radiology workflow efficiency across enterprise imaging environments. SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced details of 28 scientific abstracts accepted at the International Stroke Conference (ISC) 2026, held […]

Continue Reading →

Jupiter Endovascular Announces Completion of Enrollment in SPIRARE II Pivotal Trial

Peripheral/Endo Regulatory by 0 comments

Trial Evaluates Safety, Right Heart Functional Improvement, and Clinical Outcomes of Vertex Pulmonary Embolectomy System with Transforming Fixation (TFX) MENLO PARK, Calif. – February 4, 2026 – Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular interventions using its proprietary Transforming Fixation (TFX) technology, today announced completion of […]

Continue Reading →

Balt’s Squid™ Liquid Embolic Receives FDA Approval for Adjunctive Treatment for Patients with Chronic Subdural Hematomas

Neuro by 0 comments

BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) — Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid™ liquid embolic agent. Squid is approved for the embolization of the middle meningeal artery (MMA) as an adjunct to usual care treatment in patients with large symptomatic chronic subdural hematoma(s) (cSDH).

Continue Reading →

Catheter Precision Announces Accelerated Momentum for LockeT Device with New Hospital Approvals and Strong Q1 Adoption Outlook

Rhythm by 0 comments

FORT MILL, S.C., Feb. 04, 2026 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a medical device company specializing in advanced electrophysiology solutions, today announced a surge in hospital evaluations and approvals for its LockeT suture retention device. As the company enters the first quarter of 2026, it reports significant progress in domestic and international product adoption, driven by successful clinical outcomes and the device’s ability to streamline hospital workflows.

Continue Reading →

Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease

Coronary/Structural Heart by 0 comments

GOTHENBURG, Sweden, Feb. 4, 2026 /PRNewswire/ — Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that it is broadening the development focus…

Continue Reading →
1 2 3 … 1,300